Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-02 Purchase |
2024-04-03 6:50 pm |
Xilio Therapeutics Inc. | XLO | GILEAD SCIENCES INC. 10% Owner |
485,250 | $0.76 | $368,790 | 11,227,923 (Direct) |
View |
| 2024-04-01 Sale |
2024-04-02 6:38 pm |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
2,000 | $72.96 | $145,920 | 96,304 (Direct) |
View |
| 2024-02-28 Sale |
2024-02-29 6:35 pm |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
10,230 | $72.82 | $744,984 | 92,706 (Direct) |
View |
| 2024-02-12 Purchase |
2024-02-13 5:48 pm |
Kyverna Therapeutics Inc. | KYTX | GILEAD SCIENCES INC. 10% Owner |
910,000 | $22 | $20,020,000 | 4,126,119 (Direct) |
View |
| 2024-01-29 Purchase |
2024-01-31 5:00 pm |
Arcus Biosciences Inc. | RCUS | GILEAD SCIENCES INC. 10% Owner |
15,238,095 | $21 | $319,999,995 | 30,061,124 (Direct) |
View |
| 2024-01-16 Sale |
2024-01-17 6:01 pm |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
5,000 | $85.78 | $428,900 | 101,534 (Direct) |
View |
| 2024-01-09 Sale |
2024-01-10 3:58 pm |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
8,242 | $85.23 | $702,466 | 82,729 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-05-08 Option Award |
2024-05-09 5:23 pm |
N/A 2034-05-08 |
GILEAD SCIENCES INC. | GILD | WELTERS ANTHONY Director |
14,958 | $0 | 22,880 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-09 5:16 pm |
N/A 2034-05-08 |
GILEAD SCIENCES INC. | GILD | MANWANI HARISH Director |
14,958 | $0 | 25,521 (Direct) |
View |
| 2024-05-08 Tax Withholding |
2024-05-09 5:16 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | MANWANI HARISH Director |
451 | $64.92 | 25,521 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-09 5:08 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Bluestone Jeffrey Director |
14,958 | $0 | 16,845 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-09 3:46 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Horning Sandra Director |
14,958 | $0 | 20,449 (Direct) |
View |
| 2024-05-08 Option Award |
2024-05-09 3:38 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Kramer Kelly A. Director |
14,958 | $0 | 30,242 (Direct) |
View |
| 2024-04-25 Tax Withholding |
2024-04-26 4:30 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
158 | $65.27 | 53,682 (Direct) |
View |
| 2024-04-25 Exercise |
2024-04-26 4:30 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
515 | $0 | 53,682 (Direct) |
View |
Ownership |
2024-04-19 4:31 pm |
N/A N/A |
LEAP THERAPEUTICS INC. | LPTX | GILEAD SCIENCES INC. 10% Owner |
0 | $0 | 5,319,148 (Direct) |
View |
Ownership |
2024-04-03 6:48 pm |
N/A N/A |
Xilio Therapeutics Inc. | XLO | GILEAD SCIENCES INC. 10% Owner |
0 | $0 | 6,860,223 (Direct) |
View |
| 2024-03-28 Option Award |
2024-03-29 5:19 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Lofton Kevin E Director |
34 | $0 | 3,258 (Direct) |
View |
| 2024-03-10 Tax Withholding |
2024-03-12 4:19 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
846 | $75.12 | 138,088 (Direct) |
View |
| 2024-03-10 Option Award |
2024-03-12 4:19 pm |
N/A 2034-03-10 |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
65,795 | $0 | 138,088 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-12 4:19 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
2,555 | $0 | 138,088 (Direct) |
View |
| 2024-03-10 Tax Withholding |
2024-03-12 3:57 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
790 | $75.12 | 94,565 (Direct) |
View |
| 2024-03-10 Option Award |
2024-03-12 3:57 pm |
N/A 2034-03-10 |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
18,485 | $0 | 94,565 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-12 3:57 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
2,682 | $0 | 94,565 (Direct) |
View |
| 2024-03-10 Tax Withholding |
2024-03-11 9:14 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
4,803 | $75.12 | 304,272 (Direct) |
View |
| 2024-03-10 Option Award |
2024-03-11 9:14 pm |
N/A 2034-03-10 |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
107,300 | $0 | 304,272 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-11 9:14 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
10,401 | $0 | 304,272 (Direct) |
View |
| 2024-03-10 Tax Withholding |
2024-03-11 9:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
13,782 | $75.12 | 1,080,883 (Direct) |
View |
| 2024-03-10 Option Award |
2024-03-11 9:11 pm |
N/A 2034-03-10 |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
334,040 | $0 | 1,080,883 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-11 9:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
29,940 | $0 | 1,080,883 (Direct) |
View |
| 2024-03-10 Tax Withholding |
2024-03-11 9:03 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
4,559 | $75.12 | 320,955 (Direct) |
View |
| 2024-03-10 Option Award |
2024-03-11 9:03 pm |
N/A 2034-03-10 |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
105,275 | $0 | 320,955 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-11 9:03 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
9,844 | $0 | 320,955 (Direct) |
View |
| 2024-03-10 Tax Withholding |
2024-03-11 8:59 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
4,505 | $75.12 | 332,733 (Direct) |
View |
| 2024-03-10 Option Award |
2024-03-11 8:59 pm |
N/A 2034-03-10 |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
105,275 | $0 | 332,733 (Direct) |
View |
| 2024-03-10 Exercise |
2024-03-11 8:59 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
9,732 | $0 | 332,733 (Direct) |
View |
| 2024-02-12 Conversion |
2024-02-13 5:48 pm |
N/A N/A |
Kyverna Therapeutics Inc. | KYTX | GILEAD SCIENCES INC. 10% Owner |
17,853,002 | $0 | 4,126,119 (Direct) |
View |
Ownership |
2024-02-07 5:35 pm |
N/A N/A |
Kyverna Therapeutics Inc. | KYTX | GILEAD SCIENCES INC. 10% Owner |
0 | $0 | 3,216,119 (Direct) |
View |
| 2024-02-02 Option Award |
2024-02-06 6:01 pm |
N/A 2034-02-02 |
GILEAD SCIENCES INC. | GILD | LOVE TED W Director |
3,508 | $0 | 3,508 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 2:42 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
76,853 | $0 | 102,616 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 2:42 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
23,709 | $78.26 | 102,616 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 2:34 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
74,055 | $0 | 113,147 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 2:34 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
22,509 | $78.26 | 113,147 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 2:19 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
4,646 | $0 | 11,728 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 2:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
74,961 | $0 | 129,436 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 2:11 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
23,410 | $78.26 | 129,436 (Direct) |
View |
| 2024-01-31 Option Award |
2024-02-02 1:40 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
230,747 | $0 | 468,689 (Direct) |
View |
| 2024-01-31 Tax Withholding |
2024-02-02 1:40 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
79,335 | $78.26 | 468,689 (Direct) |
View |
| 2024-01-25 Tax Withholding |
2024-01-26 4:31 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
194 | $80.23 | 38,905 (Direct) |
View |
| 2024-01-25 Exercise |
2024-01-26 4:31 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Telman Deborah H EVP, Corporate Affairs & GC |
514 | $0 | 38,905 (Direct) |
View |
| 2023-12-28 Option Award |
2023-12-29 4:36 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Lofton Kevin E Director |
30 | $0 | 3,224 (Direct) |
View |
Ownership |
2023-12-28 5:09 pm |
N/A N/A |
Arcellx Inc. | ACLX | GILEAD SCIENCES INC. 10% Owner |
0 | $0 | 6,720,803 (Direct) |
View |
Ownership |
2023-12-22 4:07 pm |
N/A N/A |
HOOKIPA Pharma Inc. | HOOK | GILEAD SCIENCES INC. 10% Owner |
0 | $0 | 18,759,465 (Direct) |
View |
| 2023-12-10 Tax Withholding |
2023-12-11 7:15 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
1,247 | $79.02 | 130,958 (Direct) |
View |
| 2023-12-10 Exercise |
2023-12-11 7:15 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Mercier Johanna Chief Commercial Officer |
2,730 | $0 | 130,958 (Direct) |
View |
| 2023-12-10 Tax Withholding |
2023-12-11 7:10 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
1,269 | $79.02 | 112,615 (Direct) |
View |
| 2023-12-10 Exercise |
2023-12-11 7:10 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Parsey Merdad Chief Medical Officer |
2,779 | $0 | 112,615 (Direct) |
View |
| 2023-12-10 Tax Withholding |
2023-12-11 7:08 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
222 | $79.02 | 46,940 (Direct) |
View |
| 2023-12-10 Exercise |
2023-12-11 7:08 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Patterson Sandra SVP, Controllership |
518 | $0 | 46,940 (Direct) |
View |
| 2023-12-10 Tax Withholding |
2023-12-11 7:04 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
3,341 | $79.02 | 498,583 (Direct) |
View |
| 2023-12-10 Exercise |
2023-12-11 7:04 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | O'Day Daniel Patrick Chairman & CEO |
7,347 | $0 | 498,583 (Direct) |
View |
| 2023-12-10 Tax Withholding |
2023-12-11 7:00 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
1,194 | $79.02 | 145,368 (Direct) |
View |
| 2023-12-10 Exercise |
2023-12-11 7:00 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
2,617 | $0 | 145,368 (Direct) |
View |
| 2023-11-10 Tax Withholding |
2023-11-13 6:21 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
804 | $75.92 | 146,562 (Direct) |
View |
| 2023-11-10 Exercise |
2023-11-13 6:21 pm |
N/A N/A |
GILEAD SCIENCES INC. | GILD | Dickinson Andrew D Chief Financial Officer |
1,912 | $0 | 146,562 (Direct) |
View |